Contributors FDA Health Law Policy Jacob Sherkow Nicholson Price Pharmaceuticals Public Health Rachel Sachs Vaccines
moderna
-
-
Biotechnology Featured Generic Drugs Global Health Health Law Policy Intellectual Property International Jorge Contreras Market Design Pharmaceuticals Public Health Resource Allocation VaccinesUS Support for a WTO Waiver of COVID-19 Intellectual Property – What Does it Mean?
Read more: US Support for a WTO Waiver of COVID-19 Intellectual Property – What Does it Mean? -
Biotechnology Featured Health Law Policy Intellectual Property International Pharmaceuticals Public Health Resource Allocation VaccinesThe COVID-19 Vaccine Patent Waiver: The Wrong Tool for the Right Goal
Read more: The COVID-19 Vaccine Patent Waiver: The Wrong Tool for the Right Goal -
Chloe Reichel Elizabeth Sepper Featured First Amendment Health Law Policy History Immunization Judicial Opinions Petrie-Flom Center Philosophy Public Health Supreme Court Vaccines5 Questions About COVID-19 and Religious Exemptions
Read more: 5 Questions About COVID-19 and Religious Exemptions -
Dorit Reiss FDA Featured Health Law Policy I. Glenn Cohen Immunization Petrie-Flom Center Public Health VaccinesCan Colleges and Universities Require Student COVID-19 Vaccination?
Read more: Can Colleges and Universities Require Student COVID-19 Vaccination? -
Bioethics Doctor-Patient Relationship Health Law Policy Medical Tourism Patient Care Pharmaceuticals Public Health Resource Allocation Social Determinants of Health VaccinesHow the Government Can Prevent Individuals from Using Wealth to Cut the Vaccine Line
Read more: How the Government Can Prevent Individuals from Using Wealth to Cut the Vaccine Line -
Biotechnology Chloe Reichel Featured Health Law Policy Intellectual Property Pharmaceuticals Vaccines4 Things to Know About Intellectual Property, Patent Pledges, and COVID-19 Vaccines
Read more: 4 Things to Know About Intellectual Property, Patent Pledges, and COVID-19 Vaccines -
Contributors FDA Health Law Policy Jacob Sherkow Nicholson Price Patient Care Pharmaceuticals Public Health Rachel Sachs VaccinesHow Can Policymakers Overcome the Hurdles to Scaling up Antibody Manufacturing?
Read more: How Can Policymakers Overcome the Hurdles to Scaling up Antibody Manufacturing? -
Can Employers Mandate a Vaccine Under Emergency Use Authorization?
Read more: Can Employers Mandate a Vaccine Under Emergency Use Authorization? -
Contributors FDA Health Law Policy Jacob Sherkow Nicholson Price Patient Care Pharmaceuticals Public Health Rachel Sachs VaccinesWhy Aren’t Therapeutic Antibodies Being Used More to Treat COVID-19?
Read more: Why Aren’t Therapeutic Antibodies Being Used More to Treat COVID-19?